175713-98-1

Basic information

• Product Name: 1H-Benzimidazole, 1-phenyl-2-[4-[3-(1-piperidinyl)propoxy]phenyl]-
• CAS NO: 175713-98-1
• Molecular Formula: C27H29N3O
• Molecular Weight: 411.547
• Mol File: 175713-98-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Benzimidazole, 1-phenyl-2-[4-[3-(1-piperidinyl)propoxy]phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole, 1-phenyl-2-[4-[3-(1-piperidinyl)propoxy]phenyl]-(175713-98-1)
• EPA Substance Registry System: 1H-Benzimidazole, 1-phenyl-2-[4-[3-(1-piperidinyl)propoxy]phenyl]-(175713-98-1)

Safety Data

• Hazardous Substances Data: 175713-98-1(Hazardous Substances Data)

Upstream product

• 534-85-0 N-phenyl-1,2-benzenediamine 
• 2620-84-0 2-(4-methoxyphenyl)-1-phenyl-1H-benzo[d]imidazole 
• 100-07-2 4-methoxy-benzoyl chloride 
• 1458-63-5 N-(3-chloropropyl)-piperidine 
• 94212-06-3 4-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenol 

Relevant articles and documents

Methods of treating or preventing sleep apnea

This invention provides methods for the treatment or prevention of sleep apnea in a mammal which compris administering to a mammal in need thereof an effective amount of a substituted benzimidazole, or a pharmaceutically acceptable salt or solvate thereof.

Non-peptidyl tachykinin receptor antagonists

This invention provides novel substituted benzimidazoles of formula II which are useful as tachykinin receptor antagonists. This invention also provides methods for treating a condition associated with an excess of tachykinin which comprises administering to a mammal in need thereof one of a series of substituted benzimidazoles. This invention further provides pharmaceutical formulations comprising one or more of the substituted benzimidazoles of the present invention in association with pharmaceutical carriers, diluents, or excipients. A and Ra-Re are as defined in the description.